TAILIEUCHUNG - Survival of occlusal ART restorations using high-viscosity glass-ionomer with and without chlorhexidine: A 2-year split-mouth quadruple-blind randomized controlled clinical trial

The study question was whether the use of high-viscosity glass-ionomer with chlorhexidine (HVGIC/ CHX) for the Atraumatic Restorative Treatment (ART) prepared cavities could achieve a higher restoration survival percentage and be more effective for preventing dentine carious lesions adjacent to the restoration than the use of HVGIC without CHX. The study followed a split-mouth, quadruple-blind, randomized controlled clinical design and lasted 2 years. Patients with at least two small- to medium-sized occlusal cavities were included. The occlusal cavities were prepared according to the ART method and restored with HVGIC/CHX (test) and HVGIC (control). A replica of all restorations available and digital photographs were fabricated at baseline and after , 1, and 2 years and evaluated by two examiners using the ART and Federation Dentaire International (FDI) restoration assessment criteria. Survival curves were constructed using the Kaplan-Meier method, and the log-rank test was used to test for significance between the survival percentages. A total of 100 subjects with an average age of years participated. According to the ART restoration assessment criteria, the 2-year survival percentages of ART/HVGIC/CHX () and ART/HVGIC () did not differ significantly and no significant difference was found between the test () and control () groups according to the FDI restoration assessment criteria. Eight and five occlusal restorations failed according to the ART and FDI restoration criteria, respectively. | Survival of occlusal ART restorations using high-viscosity glass-ionomer with and without chlorhexidine: A 2-year split-mouth quadruple-blind randomized controlled clinical trial

• Y khoa - Dược
• Atraumatic Restorative Treatment
• Glass ionomer cement
• High viscosity glass ionomer cement
• Survival percentage
• Clinical trial
• BMC Cancer
• Clinical trial protocol
• Clear cell renal cell carcinoma
• Phase II clinical trial
• Bayesian adaptive trial
• Clinical trial registry
• Interventional studies
• Observational studies
• Clinicaltrials gov
• International Clinical Trials Registry
• Mycophenolate mofetil
• Phase II
• Clinical outcomes
• Pharmacokinetic parameters
• Clinical trial enrollment
• Population based
• Therapeutic clinical trial
• Multiple logistic regression analysis
• Public health
• Indigenous health
• Clinical trial registration
• Burden of disease
• Population health
• Minority health
• Breast cancer
• During chemotherapy
• Non inferiority clinical trial
• Allocated randomly
• Randomized clinical trial
• Evaluating results
• Trial application
• Trial application of some clinical teaching
• Learning methods
• Learning methods for medical students
• Phase III clinical trial
• Gastric cancer
• Sentinel lymph node
• Laparoscopic surgery
• BMC Musculoskeletal Disorders
• Low back pain
• Pilot trial
• Sensor biofeedback
• Musculoskeletal disorders
• Modified DCvaccine
• Non small cell lung cancer
• Phase I clinical trial
• Dose escalation trial
• BMC Anesthesiology
• Postoperative nausea and vomiting
• Selective outcome reporting
• Systematic review
• Trial registration
• Esophageal cancer
• Cell death protein 1
• Preoperative chemoradiotherapy
• Proximal tibia fracture
• Polyaxial locking plate
• Radiological outcomes
• Comparable clinical
• Germ cell tumours
• Phase 3 trial
• Affordable intervention
• Randomised clinical trial
• Hip osteoarthritis
• Intra articular corticosteroid injection
• Hip injection trial
• Randomised controlled trial
• Using a Randomised
• Controlled Clinical Trial
• Evaluate an NLG System
• báo cáo khoa học
• mô hình ngôn ngữ
• xử lý ngôn ngữ tự nhiên
• Lower body positive pressure support
• Gait training
• Conventional treadmill gait training
• A randomized clinical trial
• Body positive pressure treadmill
• Hydrocortisone relieves
• Immediate post operative scrotal edema
• Inguinal varicocelectomy
• Prospective clinical trial
• Randomly classified into group A
• BMC Pediatrics
• Pediatric clinical trial
• Inherited retinal disease
• Stem cell therapy
• Gene therapy
• Risk communication
• Informed consent
• Etomidate anesthesia
• Respiratory depression
• Haemodynamic responses
• Procedure related time
• Neoadjuvant chemoradiotherapy
• Adjuvant chemotherapy
• Locally advanced rectal cancer
• Yield pathological stage
• Cancer related fatigue
• Performance status
• Chronic Illness Therapy
• Prostatic neoplasms
• Castration resistant
• Castration resistant prostate cancer
• Palliative care
• Early integrated care
• Quality of life research
• Cost effectiveness
• Colon carcinoma
• Peritoneal carcinomatosis
• Hyperthermic intra peritoneal chemotherapy
• Mitomycin C